secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jazz Pharmaceuticals plc (JAZZ)
CIK:        0001232524
Form:       8-K
Filed at:   2026-05-29T20:05:00+00:00
Accession:  0001628280-26-039147
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Anne O'Riordan not standing for re-election at Jazz's 2026 annual meeting
--------------------------------------------------------------------------------

- Class III director Anne O'Riordan will not seek re-election at the 2026 annual meeting, continuing board refreshment.
- O'Riordan's decision was not due to any dispute or disagreement with the company or board.
- Board will continue to evaluate composition; no immediate replacement announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1232524/000162828026039147/0001628280-26-039147-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1232524/000162828026039147/jazz-20260525.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-039147

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer